DVA
DaVita insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$178.72
+39.5% over 12 months
Share price and insider trades
DVA closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$509M
Insiders buying0
Insiders selling6
Valuation, profit and volume
P/E (trailing)15.1Sector median 24.5
Market value$11.40BMedical Care Facilities
Profit margin6.0%Revenue growth +5.2%
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 DaVita insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $509M. 3 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 72 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 4SEC | Berkshire Hathaway Inc10% Owner | Sell | 182,980 | $199.55 | $36.5M | -10.4% | — |
| Jun 17SEC | Javier RodriguezCEO | Sell | 39,407 | $209.28 | $8.2M | -14.6% | — |
| Jun 17SEC | Javier RodriguezCEO | Sell | 30,000 | $209.50 | $6.3M | -14.7% | — |
| Jun 17SEC | Kathleen Alyce WatersGeneral Counsel | Sell Plan | 8,950 | $207.84 | $1.9M | -14.0% | — |
| Jun 17SEC | Kathleen Alyce WatersGeneral Counsel | Sell Plan | 6,455 | $209.17 | $1.4M | -14.6% | — |
| May 18SEC | James O HeartyChief Compliance Officer | Sell | 15,000 | $193.98 | $2.9M | -7.9% | — |
| May 13SEC | David Paul MaughanCOO | Sell | 13,456 | $199.25 | $2.7M | -10.3% | — |
| May 13SEC | David Paul MaughanCOO | Sell | 7,073 | $199.15 | $1.4M | -10.3% | — |
| May 11SEC | Joel AckermanCFO | Sell | 51,471 | $192.10 | $9.9M | -7.0% | — |
| May 8SEC | James O HeartyChief Compliance Officer | Sell Plan | 2,184 | $174.87 | $382K | +2.2% | — |
| May 5SEC | Berkshire Hathaway Inc10% Owner | Sell | 1,220,376 | $149.84 | $183M | +19.3% | — |
| Feb 2SEC | Berkshire Hathaway Inc10% Owner | Sell | 1,658,480 | $120.56 | $200M | +48.2% | — |
| Oct 29SEC | Berkshire Hathaway Inc10% Owner | Sell | 401,514 | $135.36 | $54.3M | +32.0% | — |
Insiders at DaVita
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Berkshire Hathaway Inc10% Owner | — | $474M | Aug 4, 2026 | — |
| Javier RodriguezCEO | — | $14.5M | Jun 17, 2026 | — |
| Joel AckermanCFO | — | $9.9M | May 11, 2026 | — |
| David Paul MaughanCOO | — | $4.1M | Sep 24, 2026 | — |
| James O HeartyChief Compliance Officer | — | $3.3M | May 18, 2026 | — |
| Kathleen Alyce WatersGeneral Counsel | — | $3.2M | Jun 17, 2026 | — |
| Phyllis R YaleDirector | — | — | Aug 18, 2026 | — |
| Pamela M ArwayDirector | — | — | Aug 18, 2026 | — |
| Wendy Lee SchoppertDirector | — | — | Aug 18, 2026 | — |
| Dennis W PullinDirector | — | — | Aug 18, 2026 | — |
| Gregory J. MooreDirector | — | — | Aug 18, 2026 | — |
| Adam H SchechterDirector | — | — | Aug 18, 2026 | — |
| Barbara J DesoerDirector | — | — | Aug 18, 2026 | — |
| Jason M. HollarDirector | — | — | Aug 18, 2026 | — |
| Christopher Michael BerryChief Accounting Officer | — | — | Mar 17, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about DVA insiders
Are DaVita insiders buying DVA stock?
In the past 12 months, 0 insiders reported open-market purchases of DVA worth $0.
Are DaVita insiders selling DVA stock?
6 insiders reported sales worth $509M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.